5 results
8-K
EX-10.1
NRBO
NeuroBo Pharmaceuticals Inc
22 Dec 22
Departure of Directors or Certain Officers
5:08pm
); market share; cash flow; cash flow per share; share price performance; debt reduction; customer satisfaction; stockholders’ equity; capital expenditures
8-K
EX-10.1
NRBO
NeuroBo Pharmaceuticals Inc
4 Nov 21
NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President
8:10am
development milestones); geographic business expansion; cost targets, cost reductions or savings; customer satisfaction; operating efficiency; acquisition
- Prev
- 1
- Next